首页> 外文OA文献 >Efficacy and Toxicity of Idarubicin Versus High-dose Daunorubicin for Induction Chemotherapy in Adult Acute Myeloid Leukemia: A Systematic Review and Meta-analysis

【2h】

Efficacy and Toxicity of Idarubicin Versus High-dose Daunorubicin for Induction Chemotherapy in Adult Acute Myeloid Leukemia: A Systematic Review and Meta-analysis

机译：紫芽蛋白的疗效和毒性与成人敏感白血病成人急性化疗的高剂量Daunorubicin：系统审查和荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Weerapat Owattanapanich; Natthida Owattanapanich; Smith Kungwankiattichai; Patompong Ungprasert; Theera Ruchutrakool;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and Toxicity of Idarubicin Versus High-dose Daunorubicin for Induction Chemotherapy in Adult Acute Myeloid Leukemia: A Systematic Review and Meta-analysis [J] . Owattanapanich Weerapat, Owattanapanich Natthida, Kungwankiattichai Smith, Clinical lymphoma, myeloma & leukemia . 2018,第12期

机译：含紫芽蛋白的疗效和毒性与高剂量Daunorubicin在成人急性髓性白血病中诱导化疗：系统评价和荟萃分析
2. Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10. [J] . Mandelli F, Vignetti M, Suciu S Journal of Clinical Oncology . 2009,第32期

机译：柔红霉素对米托蒽醌对伊达比星对成人急性髓性白血病的诱导和巩固化疗：EORTC和GIMEMA组研究AML-10。
3. Analysis of efficacy and cost-effectiveness of high-dose arabinoside versus daunorubicin chemotherapy in older adult patients with acute myeloid leukemia by cytogenetic risk profile: retrospective review from China. [J] . Huang BT, Wang Y, Du QF, International journal of hematology . 2011,第4期

机译：通过细胞遗传学危险因素分析大剂量阿糖苷与柔红霉素对老年急性髓细胞白血病患者的疗效和成本效益：来自中国的回顾性回顾。
4. Ras gene mutation in acute myeloid leukemia and Myelodysplastic syndromes: a meta-analysis of its occurrence and prognostic relevance [C] . Cheng Jingru, Wang Peng, Zhang Tai, International Conference on Advanced Materials and Computer Science . 2016

机译：RAS基因突变在急性髓性白血病和髓细胞增强综合征中：荟萃分析其发生和预后相关性
5. Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study [D] . Harada Yasuhiko, 原田靖彦 2019

机译：根据2017年日本成人白血病研究组（JALSG）AML201研究治疗的成人急性髓性白血病患者的遗传学预测，根据2017 ELN风险分层进行预后分析
6. Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10 [O] . Franco Mandelli, Marco Vignetti, Stefan Suciu, -1

机译：柔红霉素与米托蒽醌与依达比星对成人急性粒细胞白血病的诱导和巩固化学治疗：EORTC和GIMEMA组研究AML-10
7. Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA groups study AML-10 [O] . Mandelli F, Vignetti M, Suciu S, 2009

机译：柔红霉素对米托蒽醌对伊达比星对成人急性粒细胞白血病的诱导和巩固化疗：EORTC和GIMEMA研究组AML-10

Efficacy and Toxicity of Idarubicin Versus High-dose Daunorubicin for Induction Chemotherapy in Adult Acute Myeloid Leukemia: A Systematic Review and Meta-analysis

著录项

引文网络

相似文献

相关主题

期刊订阅